Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Aug 27, 2023 6:31pm
227 Views
Post# 35607447

RE:RE:RE:RE:Cmon Mat!(not Brad).....let’s see a nice positive update!

RE:RE:RE:RE:Cmon Mat!(not Brad).....let’s see a nice positive update!
Hello Westcoast and as I see it, the problem with waiting too long is another standard of care in the way as is what has happened with mbc as it appears they are kind of in a holding pattern with this to wait for the ADC's to play out and also OS on the Bracelet which I had stated a long time ago that this would most likely happen.That puts us into 2024 sometime just for the readout and as we know from the prospectus that onc is commiting half a million as compared to over 10 million for the panc which is a telling story as to which indication has the lead IMO. Shareholder value is most interesting as is that perceived by management as to what they feel is fair value or the long term shareholders who have been in this forever.
One would hope that if an offer of 1.5 billion has been put forward that the company would be obligated to present to shareholders but do not think that this has happened as BP could kind of request politley that this be presented as I understand it. Also if a reasonable offer was put forward it might put pressure on another BP to beat the offer....Wish I knew more about how this works or if the company has even had any offers. Also another problem with waiting too long is that something could go wrong in the trial as with the Bracelet and the CI not panning out which basically pushed our timeframe back even more for mbc.
All IMO of course but this is what has happened to date so far with the trials.
<< Previous
Bullboard Posts
Next >>